Sirolimus: A Successful Medical Treatment for Head and Neck Lymphatic Malformations

Clicks: 376
ID: 9906
2019
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #3 of 28 articles by views in case reports in otolaryngology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Lymphatic malformations are abnormalities that arise in the developing lymphatic system, most frequently presenting in the head and neck. They are typically treated with sclerotherapy, laser therapy, or surgery for localized lesions. Sirolimus, an inhibitor of the mammalian target of rapamycin, is a relatively new medical therapy for the treatment of vascular malformations. This case report presents the improvements and complications seen in a female infant who was diagnosed with a large lymphatic malformation on prenatal ultrasound and has been treated with sirolimus during the first 9 months of life.
Reference Key
steven2019sirolimuscase Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Curry, Steven;Logeman, Andrew;Jones, Dwight;Curry, Steven;Logeman, Andrew;Jones, Dwight;
Journal case reports in otolaryngology
Year 2019
DOI
10.1155/2019/2076798
URL
https://www.hindawi.com/journals/criot/2019/2076798/abs/
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.